Vimarsana
Biggest News Aggregation in the World

Page 20 - Biological E News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biological E. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biological E Today - Breaking & Trending Today

With 100 crore COVID vaccine doses mark, India's role as pharmacy of world becomes more entrenched - Vimarsana News

With 100 crore COVID vaccine doses mark, India's role as pharmacy of world becomes more entrenched

New Delhi: As the country achieved the milestone of vaccinating over 100 crore Indians against COVID-19 on Thursday, India's role as the pharmacy of the world became more entrenched with the nation...

India to procure over 30 crore COVID-19 vaccine doses per month by January: Sources - Vimarsana News

India to procure over 30 crore COVID-19 vaccine doses per month by January: Sources

India will have a capacity of more than 30 crores by next year per month, which includes Covishield, Covaxin, ZyCoV-D and Biological E, said sources. 

Source: india.com
Biological E to submit final data on its COVID-19 vaccine Corbevax till November end - Vimarsana News

Biological E to submit final data on its COVID-19 vaccine Corbevax till November end

The Corbevax is the third made-in-India vaccine against coronavirus, the other two indigenous vaccines are Covaxin and ZyCoV-D

Biological E to submit final data of its Covid vaccine Corbevax till November end: Report - Vimarsana News

Biological E to submit final data of its Covid vaccine Corbevax till November end: Report

Biological E to submit final data of its Covid vaccine Corbevax till November end: Report

Biological E to submit final data on its COVID-19 vaccine Corbevax till November end - Vimarsana News

Biological E to submit final data on its COVID-19 vaccine Corbevax till November end

The Corbevax is the third made-in-India vaccine against coronavirus, the other two indigenous vaccines are Covaxin and ZyCoV-D